Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Lancet Oncol. 2009 Dec 23;11(2):129–135. doi: 10.1016/S1470-2045(09)70354-7

Figure 2. Waterfall plot of best responses, as percentage decrease in tumour size by RECIST criteria, of the target lesions in 22 evaluable patients.

Figure 2

Green bars are patients with disease progression (increase in target-lesion size); blue bars are patients with a decrease in size of the target lesions. The numbers above/below the bars represent the number of treatment cycles patients received before withdrawal due to disease progression. RECIST=Response Evaluation Criteria in Solid Tumours. DSRC=desmoplastic small round cell tumour. *Remains on study.†Partial response in soft-tissue disease but progressive disease with a new bone lesion. ‡Patient with a partial response after treatment and complete response after surgery. §Reduction in target lesions after two cycles of treatment and radiotherapy to the mediastinum.